AFT PHARMACEUTICALS LIMITED — Earnings Release 2021

Nov 17, 2021

==> picture [174 x 30] intentionally omitted <==

Results for announcement to the market	Results for announcement to the market	Results for announcement to the market
AFT Pharmaceuticals LimitedReporting PeriodPrevious Reporting PeriodCurrency	6 months to September 30 2021 6 months to September 30 2020 NZ$
	Amount (000s)Percentage change
Revenue from continuingoperations	$55,513Up 14%
Total Revenue	$55,513Up 14%
Net profit/(loss) from continuingoperations	$5,491Up 127%
Total net profit/(loss)	$5,491Up 127%
Interim/Final Dividend
Quoted Equity Securities:
Amount per Quoted EquitySecurity	No dividends have been paid on ordinary shares and it iscurrently not proposed to pay dividends.
Imputed amount per QuotedEquity Security	Not Applicable
Record Date	Not Applicable
Dividend Payment Date	Not Applicable
Unquoted Equity Securities:
Amount per UnquotedRedeemable Preference Share	Not Applicable
Imputed Amount per UnquotedRedeemable Preference Share	Not Applicable
Record Dates	Not Applicable
Dividend Payment Dates	Not Applicable
	Current period	Prior comparable period
Net tangible assets per QuotedEquity Security	$0.05	($0.01)
A brief explanation of any of thefigures above necessary toenable the figures to beunderstood	Accompanying this announcement are the Group’s unauditedconsolidated financial statements for the six months ended30 September 2021. These financial statements and the halfyear results commentary dated 18 November 2021 providethe balance of information requirements in accordance withNZX Listing Rule 3.5 and Appendix 2.Pursuant to ASX listing rule 1.15.3 AFT PharmaceuticalsLimited confirms that it continues to comply with the rules ofits home exchange (NZX Main Board).

==> picture [481 x 57] intentionally omitted <==

Authority for this announcement
Name of person authorised tomake this announcement	Malcolm Tubby
Contact person for thisannouncement	Malcolm Tubby, Chief Financial Officer,AFT Pharmaceuticals Ltd
Contact phone number	+64 9 488 0232
Contact email address	malcolm@aftpharm.com
Date of release through MAP	18 November 2021

Unaudited financial statements accompany this announcement.

AFT Pharmaceuticals Limited, Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622, New Zealand Incorporated in New Zealand ARBN: ARBN 609 017 969